A real-world effectiveness study of Sofosbuvir/Velpatasvir in patients with hepatitis C infection
Latest Information Update: 02 Apr 2020
At a glance
- Drugs Sofosbuvir/velpatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
Most Recent Events
- 02 Apr 2020 Primary endpoint (Sustained virologic response) was met.
- 02 Apr 2020 New trial record
- 11 Mar 2020 Results presented at the 27th Conference on Retroviruses and Opportunistic Infections